We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 6.99%
2 Financials 5.48%
3 Industrials 4.89%
4 Consumer Discretionary 4.88%
5 Healthcare 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTI icon
7076
PUT
W&T Offshore
WTI
$492M
$39K ﹤0.01%
+12,700
New +$26.9K
NWY
7077
DELISTED
New York & Co Inc
NWY
$39K ﹤0.01%
+18,649
New +$31.6K
GLOWE
7078
DELISTED
GLOWPOINT INC
GLOWE
$39K ﹤0.01%
154,747
+59,541
+63% +$15K
BBOX
7079
PUT
DELISTED
Black Box Corp
BBOX
$39K ﹤0.01%
+11,900
New +$63.8K
SID icon
7080
CALL
Companhia Siderúrgica Nacional
SID
$1.25B
$38K ﹤0.01%
12,700
-12,000
-49% -$32.2K
NMTR
7081
DELISTED
9 Meters Biopharma
NMTR
$38K ﹤0.01%
+271
New +$42.4K
AXAS
7082
CALL
DELISTED
Abraxas Petroleum Corp
AXAS
$38K ﹤0.01%
+1,000
New +$34K
PRKR
7083
CALL
DELISTED
Parkervision Inc
PRKR
$38K ﹤0.01%
24,100
+8,800
+58% +$16K
MOBL
7084
PUT
DELISTED
MobileIron, Inc.
MOBL
$38K ﹤0.01%
+10,400
New +$46.7K
ADVM
7085
DELISTED
Adverum Biotechnologies
ADVM
$37K ﹤0.01%
+1,015
New +$28.2K
AMRN
7086
PUT
Amarin Corp
AMRN
$301M
$37K ﹤0.01%
535
-500
-48% -$35.4K
CIG icon
7087
PUT
CEMIG Preferred Shares
CIG
$6.15B
$37K ﹤0.01%
29,427
-5,493
-16% -$7.49K
TGB
7088
PUT
Trekor Metals
TGB
$3.1B
$37K ﹤0.01%
20,000
-18,300
-48% -$30K
CSCI
7089
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$37K ﹤0.01%
+181
New +$33.3K
ZN
7090
DELISTED
Zion Oil & Gas, Inc.
ZN
$37K ﹤0.01%
+10,938
New +$40.2K
AST
7091
CALL
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$37K ﹤0.01%
+11,000
New +$37K
CARM
7092
DELISTED
Carisma Therapeutics
CARM
$36K ﹤0.01%
+1,137
New +$31.8K
WTT
7093
DELISTED
Wireless Telecom Group, Inc.
WTT
$36K ﹤0.01%
+21,285
New +$31.5K
INTX
7094
DELISTED
Intersections, Inc.
INTX
$36K ﹤0.01%
10,685
-2,890
-21% -$11.1K
NLST
7095
DELISTED
Netlist, Inc.
NLST
$36K ﹤0.01%
+48,700
New +$43.6K
LCTX icon
7096
CALL
Lineage Cell Therapeutics
LCTX
$282M
$35K ﹤0.01%
14,059
-2,400
-15% -$5.95K
SCU
7097
PUT
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$35K ﹤0.01%
1,090
-560
-34% -$16.6K
STAB
7098
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$35K ﹤0.01%
10,032
-5,686
-36% -$16.1K
CORV
7099
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$35K ﹤0.01%
16,339
-2,768
-14% -$9.42K
ATNM icon
7100
Actinium Pharmaceuticals
ATNM
$24.8M
$34K ﹤0.01%
+1,952
New +$42.8K

Similar funds

Citadel Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Citadel Advisors held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.

  • Citadel Advisors's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Citadel Advisors added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Citadel Advisors's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Citadel Advisors fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Citadel Advisors's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Citadel Advisors opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.